CCL7



CCL7

Q1QQ1P2PP2V3VV3G4GG4I5II5N6NN6T7TT7S8SS8T9TT9T10TT10C11CC11C12CC12Y13YY13R14RR14F15FF15I16II16N17NN17K18KK18K19KK19I20II20P21PP21K22KK22Q23QQ23R24RR24L25LL25E26EE26S27SS27Y28YY28R29RR29R30RR30T31TT31T32TT32S33SS33S34SS34H35HH35C36CC36P37PP37R38RR38E39EE39A40AA40V41VV41I42II42F43FF43K44KK44T45TT45K46KK46L47LL47... and 29 more residue(s)...... and 29 more residue(s)

SMILES None
InChIKey None
Sequence QPVGINTSTTCCYRFINKKIPKQRLESYRRTTSSHCPREAVIFKTKLDKEICADPTQKWVQDFMKHLDKKTQTPKL

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



Bioactivities

CCL7

Q1QQ1P2PP2V3VV3G4GG4I5II5N6NN6T7TT7S8SS8T9TT9T10TT10C11CC11C12CC12Y13YY13R14RR14F15FF15I16II16N17NN17K18KK18K19KK19I20II20P21PP21K22KK22Q23QQ23R24RR24L25LL25E26EE26S27SS27Y28YY28R29RR29R30RR30T31TT31T32TT32S33SS33S34SS34H35HH35C36CC36P37PP37R38RR38E39EE39A40AA40V41VV41I42II42F43FF43K44KK44T45TT45K46KK46L47LL47... and 29 more residue(s)...... and 29 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.